London, 18th November 2002
RNA interference explored in a collaboration between a top 5 Pharmaceutical company, Cyclacel Limited, the University of Cambridge and Cancer Research Technology Limited.
London, 18th November 2002
SIGNIFICANT MILESTONE ON THE ROUTE TO DESIGNER DRUGS FOR CANCER
2nd October 2002
Cancer Research Technology (CRT) is formed through the merger of Cancer Research Ventures (CRV) and Imperial Cancer Research Technology (ICRT)
19th August 2002
Cancer Pathway Targeted by a Collaboration between De Novo Pharmaceuticals Ltd and The University of Newcastle and Cancer Research Ventures Ltd
1st July 2002
Exelixis signs a Non-Exclusive License with Cancer Research Ventures, UK.
8th April 2002
Cancer Research Ventures, London Assigns New Pre-Clinical Candidate for Auto-Immune Disorders and Cancer to BioSphings AG, Heidleberg
27th March 2002
Collaboration between RiboTargets, The Institute of Cancer Research and Cancer Research Ventures - Identifying new inhibitors against the HSP90 protein family for use in cancer
|
